237 related articles for article (PubMed ID: 1548936)
1. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.
van Dongen JJ; Breit TM; Adriaansen HJ; Beishuizen A; Hooijkaas H
Leukemia; 1992; 6 Suppl 1():47-59. PubMed ID: 1548936
[TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease in acute leukemia patients.
van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
[TBL] [Abstract][Full Text] [Related]
3. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
4. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
5. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
7. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
8. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
[TBL] [Abstract][Full Text] [Related]
9. The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study.
Campana D; Yokota S; Coustan-Smith E; Hansen-Hagge TE; Janossy G; Bartram CR
Leukemia; 1990 Sep; 4(9):609-14. PubMed ID: 1975635
[TBL] [Abstract][Full Text] [Related]
10. Extensive junctional diversity of gamma delta T-cell receptors expressed by T-cell acute lymphoblastic leukemias: implications for the detection of minimal residual disease.
Breit TM; Wolvers-Tettero IL; Hählen K; van Wering ER; van Dongen JJ
Leukemia; 1991 Dec; 5(12):1076-86. PubMed ID: 1837811
[TBL] [Abstract][Full Text] [Related]
11. Pattern of T-cell receptor delta gene rearrangement by Southern blotting and polymerase chain reaction technique in Hong Kong Chinese patients with non-T-cell hematological malignancies.
Chan DW; Liang R; Kwong YL
Hematol Oncol; 1996 Jun; 14(2):57-66. PubMed ID: 8876635
[TBL] [Abstract][Full Text] [Related]
12. [The detection of minimal residual disease in leukemia by in vitro DNA amplification].
Yokota S; Seriu T; Misawa S
Rinsho Byori; 1991 Dec; 39(12):1298-307. PubMed ID: 1779467
[TBL] [Abstract][Full Text] [Related]
13. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia.
Kitchingman GR
Leukemia; 1994 Mar; 8(3):395-401. PubMed ID: 8127144
[TBL] [Abstract][Full Text] [Related]
14. Detection of minimal residual disease in acute myelogenous leukemia.
Raanani P; Ben-Bassat I
Acta Haematol; 2004; 112(1-2):40-54. PubMed ID: 15179004
[TBL] [Abstract][Full Text] [Related]
15. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR.
van der Velden VH; van Dongen JJ
Methods Mol Biol; 2009; 538():115-50. PubMed ID: 19277574
[TBL] [Abstract][Full Text] [Related]
16. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.
Germano G; del Giudice L; Palatron S; Giarin E; Cazzaniga G; Biondi A; Basso G
Leukemia; 2003 Aug; 17(8):1573-82. PubMed ID: 12886245
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
[TBL] [Abstract][Full Text] [Related]
18. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
Gameiro P; Mortuza FY; Hoffbrand AV; Foroni L
Haematologica; 2002 Nov; 87(11):1126-34. PubMed ID: 12414341
[TBL] [Abstract][Full Text] [Related]
20. Detection of T-cell receptor delta gene rearrangement by clonal specific polymerase chain reaction.
Chan DW; Liang R; Chan V; Kwong YL; Chan TK
Leukemia; 1997 Apr; 11 Suppl 3():281-4. PubMed ID: 9209365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
